规范产检在妊娠期糖尿病患者中的应用效果及对妊娠结局的影响研究

Effect of standardized production examination on gestational diabetes mellitus and its effect on pregnancy outcome

目的探讨规范产检在妊娠期糖尿病患者中的应用效果及对妊娠结局的影响。方法选取我院在2015年6月～2017年6月收治的48例妊娠期糖尿病患者,按照随机数字法将其随即分为对照组和研究组,对照组给予常规产检,研究组给予规范产检。对比分析两组患者在治疗后的血糖水平、孕期体重增长及BMI(体质指数)、孕期及产后并发症、妊娠结局及新生儿并发症情况以及患者炎性因子水平。结果两组患者治疗前血糖水平,差异无统计学意义(P>0.05),治疗后研究组患者空腹血糖、早中晚三餐2h后血糖以及睡前血糖降低幅度明显大于对照组,差异有统计学意义(P<0.05);治疗后,研究组孕妇孕期体重和BMI均显著低于对照组,差异有统计学意义(P<0.05);研究组患者的孕期及产后并发症情况明显低于对照组患者,差异有统计学意义(P<0.05);研究组患者的妊娠结局明显优于对照组患者,差异有统计学意义(P<0.05),研究组患者的新生儿并发症明显少于对照组患者,差异有统计学意义(P<0.05);治疗前两组患者的炎性因子,差异无统计学意义(P>0.05),治疗后研究组患者明显优于对照组患者,差异有统计学意义(P<0.05)。结论规范产检在妊娠期糖尿病患者中的应用效果明显,对妊娠结局产生积极地影响,安全性高,值得在临床上进一步推广应用。

Objective To explore the effect of standardized production test on gestational diabetes mellitus and its effect on pregnancy outcome. Methods 48 cases of gestational diabetes treated in our hospital in June, -2017 June 2015, were divided into the control group and the study group according to the random number method. The control group was given routine examination, and the study group was given the standard production test. The blood glucose level after treatment, weight gain during pregnancy and BMI （body mass index）, pregnancy and postpartum complications, pregnancy outcome and neonatal complications were compared and analyzed in two groups. Results There was no signifcant difference in blood glucose level between the two groups （P〉0.05）. After treatment, the decrease of blood glucose, blood glucose and blood sugar before bedtime in the study group was signifcantly higher than that of the control group （P〈0.05）. After treatment, the weight and BMI of pregnant women in the study group were signifcantly lower than that of the control group （P〈0.05）, and the study group suffered from the treatment group （P〈0.05）. The complications of pregnancy and postpartum were signifcantly lower than those of the control group （P〈0.05）, and the pregnancy outcome in the study group was obviously better than that of the control group （P〈0.05）, and the complications of the study group were signifcantly less than those of the control group （P〈0.05）, and the compliance of the patients in the study group was obviously superior to the control group （P〈0.05）. Conclusion The application of standardized production in gestational diabetes is obvious. It has a positive effect on pregnancy outcome and high safety. It is worthy of further application in clinical practice.